FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1991156937> ?p ?o ?g. }

• W1991156937 endingPage "121" @default.
• W1991156937 startingPage "115" @default.
• W1991156937 abstract "4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a carcinogenic nitrosamine produced upon curing tobacco. It is present in tobacco smoke and undergoes metabolism to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in the lungs. NNAL undergoes further uridine diphosphate glucuronosyltransferase (UGT)-mediated metabolism to give N- and O-glucuronide metabolites, which together with free (non-conjugated) NNAL are then excreted in the urine. The ability to conduct validated analyses of free and conjugated NNAL in human urine is important in order to assess inter-individual differences in lung cancer risk from exposure to cigarette smoke. The use of stable isotope dilution (SID) methodology in combination with liquid chromatography/multiple reaction monitoring/mass spectrometry (LC/MRM-MS) provides the highest bioanalytical specificity possible for such analyses. We describe a novel derivatization procedure, which results in the formation of a pre-ionized N-propyl-NNAL derivative. The increased LC/MS sensitivity arising from this derivative then makes it possible to analyze free NNAL in only 0.25 mL urine. This substantial reduction in urine volume when compared with other methods that have been developed will help preserve the limited amounts of stored urine samples that are available from on-going longitudinal biomarker studies. The new high sensitivity SID LC/MRM-MS assay was employed to determine free and conjugated NNAL concentrations in urine samples from 60 individual disease-free smokers. Effects of inter-individual differences in urinary creatinine clearance on NNAL concentrations were then assessed and three metabolizer phenotypes were identified in the 60 subjects from the ratio of urinary NNAL glucuronides/free NNAL. Poor metabolizers (PMs, 14 subjects) with a ratio of NNAL glucuronides/free NNAL <2 (mean = 1.3), intermediate metabolizers (IMs, 36 subjects) with a ratio between 2 and 5 (mean = 3.4), and extensive metabolizers (EMs, 10 subjects) with a ratio >5 (mean = 11.1). Copyright © 2010 John Wiley & Sons, Ltd." @default.
• W1991156937 created "2016-06-24" @default.
• W1991156937 creator A5007007052 @default.
• W1991156937 creator A5037072010 @default.
• W1991156937 creator A5062716732 @default.
• W1991156937 creator A5079384190 @default.
• W1991156937 creator A5086698098 @default.
• W1991156937 date "2010-12-07" @default.
• W1991156937 modified "2023-10-16" @default.
• W1991156937 title "A new liquid chromatography/mass spectrometry method for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in urine" @default.
• W1991156937 cites W1965153645 @default.
• W1991156937 cites W1965155369 @default.
• W1991156937 cites W1976429029 @default.
• W1991156937 cites W1977052256 @default.
• W1991156937 cites W1995836069 @default.
• W1991156937 cites W2000398059 @default.
• W1991156937 cites W2003500175 @default.
• W1991156937 cites W2006656345 @default.
• W1991156937 cites W2009582193 @default.
• W1991156937 cites W2012763305 @default.
• W1991156937 cites W2016968987 @default.
• W1991156937 cites W2030353836 @default.
• W1991156937 cites W2033967950 @default.
• W1991156937 cites W2037948102 @default.
• W1991156937 cites W2041575674 @default.
• W1991156937 cites W2047300770 @default.
• W1991156937 cites W2053147497 @default.
• W1991156937 cites W2053523635 @default.
• W1991156937 cites W2056646122 @default.
• W1991156937 cites W2064597525 @default.
• W1991156937 cites W2069739388 @default.
• W1991156937 cites W2073166174 @default.
• W1991156937 cites W2079100518 @default.
• W1991156937 cites W2081359173 @default.
• W1991156937 cites W2088059017 @default.
• W1991156937 cites W2104241203 @default.
• W1991156937 cites W2107832237 @default.
• W1991156937 cites W2129748624 @default.
• W1991156937 cites W2137183397 @default.
• W1991156937 cites W2145934113 @default.
• W1991156937 cites W2148862453 @default.
• W1991156937 cites W2153495110 @default.
• W1991156937 cites W2169935883 @default.
• W1991156937 doi "https://doi.org/10.1002/rcm.4824" @default.
• W1991156937 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3348551" @default.
• W1991156937 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21154658" @default.
• W1991156937 hasPublicationYear "2010" @default.
• W1991156937 type Work @default.
• W1991156937 sameAs 1991156937 @default.
• W1991156937 citedByCount "20" @default.
• W1991156937 countsByYear W19911569372012 @default.
• W1991156937 countsByYear W19911569372013 @default.
• W1991156937 countsByYear W19911569372014 @default.
• W1991156937 countsByYear W19911569372015 @default.
• W1991156937 countsByYear W19911569372016 @default.
• W1991156937 countsByYear W19911569372017 @default.
• W1991156937 countsByYear W19911569372018 @default.
• W1991156937 countsByYear W19911569372020 @default.
• W1991156937 countsByYear W19911569372023 @default.
• W1991156937 crossrefType "journal-article" @default.
• W1991156937 hasAuthorship W1991156937A5007007052 @default.
• W1991156937 hasAuthorship W1991156937A5037072010 @default.
• W1991156937 hasAuthorship W1991156937A5062716732 @default.
• W1991156937 hasAuthorship W1991156937A5079384190 @default.
• W1991156937 hasAuthorship W1991156937A5086698098 @default.
• W1991156937 hasBestOaLocation W19911569372 @default.
• W1991156937 hasConcept C114246631 @default.
• W1991156937 hasConcept C162356407 @default.
• W1991156937 hasConcept C171679685 @default.
• W1991156937 hasConcept C185592680 @default.
• W1991156937 hasConcept C2776923573 @default.
• W1991156937 hasConcept C2777395278 @default.
• W1991156937 hasConcept C2779186261 @default.
• W1991156937 hasConcept C2780026642 @default.
• W1991156937 hasConcept C43617362 @default.
• W1991156937 hasConcept C55493867 @default.
• W1991156937 hasConcept C64489805 @default.
• W1991156937 hasConceptScore W1991156937C114246631 @default.
• W1991156937 hasConceptScore W1991156937C162356407 @default.
• W1991156937 hasConceptScore W1991156937C171679685 @default.
• W1991156937 hasConceptScore W1991156937C185592680 @default.
• W1991156937 hasConceptScore W1991156937C2776923573 @default.
• W1991156937 hasConceptScore W1991156937C2777395278 @default.
• W1991156937 hasConceptScore W1991156937C2779186261 @default.
• W1991156937 hasConceptScore W1991156937C2780026642 @default.
• W1991156937 hasConceptScore W1991156937C43617362 @default.
• W1991156937 hasConceptScore W1991156937C55493867 @default.
• W1991156937 hasConceptScore W1991156937C64489805 @default.
• W1991156937 hasIssue "1" @default.
• W1991156937 hasLocation W19911569371 @default.
• W1991156937 hasLocation W19911569372 @default.
• W1991156937 hasLocation W19911569373 @default.
• W1991156937 hasLocation W19911569374 @default.
• W1991156937 hasOpenAccess W1991156937 @default.
• W1991156937 hasPrimaryLocation W19911569371 @default.
• W1991156937 hasRelatedWork W1485351367 @default.
• W1991156937 hasRelatedWork W1979794873 @default.
• W1991156937 hasRelatedWork W1988868765 @default.

• next